Respirerx Pharmaceuticals, Inc.
10-Q
Cover
Cover
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Stockholders' Deficiency (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Organization and Basis of Presentation
Business
Summary of Significant Accounting Policies
Notes Payable
Settlement and Payment Agreements
Stockholders??? Deficiency
Related Party Transactions
Commitments and Contingencies
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Notes Payable (Tables)
Stockholders??? Deficiency (Tables)
Commitments and Contingencies (Tables)
Notes Details
Business (Details Narrative)
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)
Summary of Significant Accounting Policies (Details Narrative)
Schedule of Convertible Notes Outstanding (Details)
Schedule of Convertible Notes Payable (Details)
Notes Payable (Details Narrative)
Settlement and Payment Agreements (Details Narrative)
Schedule of Warrants Activity (Details)
Schedule of Exercise Prices of Common Stock Warrants Outstanding and Exercisable (Details)
Summary of Stock Option Activity (Details)
Schedule of Exercise Prices of Common Stock Options Outstanding and Exercisable (Details)
Stockholders??? Deficiency (Details Narrative)
Related Party Transactions (Details Narrative)
Summary of Current Cash Commitments in Employment Agreements (Details)
Summary of Principal Cash Obligations and Commitments (Details)
Commitments and Contingencies (Details Narrative)
Subsequent Events (Details Narrative)
All Reports
Filing Date:
11-15-2021
Form Type:
Form 10-Q
Description:
Quarterly Report